NCT01368562View on ClinicalTrials.gov

Compassionate Use Study of Methylnaltrexone

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 24, 2003

Primary Completion Date

June 2, 2008

Study Completion Date

June 2, 2008

Conditions
Opioid-induced Constipation
Interventions
DRUG

Methylnaltrexone

Methylnaltrexone will be administered as per the dose and schedule specified in the arm.

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01368562 - Compassionate Use Study of Methylnaltrexone | Biotech Hunter | Biotech Hunter